Alambic Investment Management Portfolio holdings
Top Buys
| 1 |
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
|
+$416K |
| 2 |
CoStar Group
CSGP
|
+$207K |
| 3 |
DNOW Inc
DNOW
|
+$192K |
| 4 |
Photronics
PLAB
|
+$131K |
| 5 |
Gyre Therapeutics
GYRE
|
+$92.2K |
Top Sells
| 1 |
CLCT
Collectors Universe
CLCT
|
+$605K |
| 2 |
Materion
MTRN
|
+$581K |
| 3 |
Corteva
CTVA
|
+$581K |
| 4 |
NPTN
NEOPHOTONICS CORP
NPTN
|
+$556K |
| 5 |
SPTN
SpartanNash
SPTN
|
+$543K |
Sector Composition
| 1 | Technology | 35.8% |
| 2 | Healthcare | 31.98% |
| 3 | Industrials | 8.99% |
| 4 | Energy | 5.56% |
| 5 | Consumer Staples | 4.23% |
Similar funds
Alambic Investment Management's Q3 2020 Portfolio in Review
As of Q3 2020, Alambic Investment Management held 181 positions worth $9.12M, down 77% from $39.9M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Alambic Investment Management withdrew a net $30.4M in Q3 2020, closing 108 positions and reducing 44 holdings. Its most notable exit was Collectors Universe, an estimated $605K position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Alambic Investment Management opened a new position in Satsuma Pharmaceuticals, Inc. Common Stock worth $81K.
- Alambic Investment Management's largest Q3 2020 buy was Satsuma Pharmaceuticals, Inc. Common Stock: 20,711 shares worth $81K.
- Alambic Investment Management added most to Rimini Street in Q3 2020, an estimated $55.9K increase.
- Alambic Investment Management's biggest Q3 2020 reduction was NEOPHOTONICS CORP, cutting an estimated $556K.
- Alambic Investment Management fully exited Collectors Universe in Q3 2020, selling an estimated $605K.
- Alambic Investment Management's ten largest holdings make up 38% of its $9.12M portfolio in Q3 2020.
- Alambic Investment Management opened 18 new positions and closed 108 in Q3 2020.
- Alambic Investment Management's portfolio value fell 77% quarter-over-quarter to $9.12M.
Based on Alambic Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.